Jackson P. Tai's most recent trade in Lilly(Eli) & Co was a trade of 5 Common Stock done at an average price of $372.4 . Disclosure was reported to the exchange on April 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 372.40 per share. | 17 Apr 2023 | 5 | 63,524 (0%) | 0% | 372.4 | 1,862 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 333.67 per share. | 20 Mar 2023 | 6 | 63,519 (0%) | 0% | 333.7 | 2,002 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 6 | 63,456 (0%) | 0% | 327.5 | 1,965 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 357.67 per share. | 17 Jan 2023 | 6 | 63,450 (0%) | 0% | 357.7 | 2,146 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 63,402 (0%) | 0% | 361.2 | 179,863 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Purchase of securities on an exchange or from another person at price $ 304.19 per share. | 12 Aug 2022 | 656 | 62,857 (0%) | 0% | 304.2 | 199,549 | Common Stock |
| Mastercard | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 741 | 34,890 (0%) | 0% | 0 | Class A Common Stock | |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 263.50 per share. | 20 Dec 2021 | 8 | 62,095 (0%) | 0% | 263.5 | 2,108 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 258.43 per share. | 15 Nov 2021 | 677 | 62,035 (0%) | 0% | 258.4 | 174,957 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 258.38 per share. | 15 Nov 2021 | 8 | 61,358 (0%) | 0% | 258.4 | 2,067 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 239.00 per share. | 18 Oct 2021 | 8 | 61,349 (0%) | 0% | 239 | 1,912 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 231.67 per share. | 20 Sep 2021 | 9 | 61,341 (0%) | 0% | 231.7 | 2,085 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 270.00 per share. | 16 Aug 2021 | 7 | 61,281 (0%) | 0% | 270 | 1,890 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 234.12 per share. | 19 Jul 2021 | 8 | 61,274 (0%) | 0% | 234.1 | 1,873 | Common Stock |
| Mastercard | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 622 | 34,149 (0%) | 0% | 0 | Class A Common Stock | |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 222.67 per share. | 21 Jun 2021 | 9 | 61,266 (0%) | 0% | 222.7 | 2,004 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 195.50 per share. | 17 May 2021 | 10 | 61,205 (0%) | 0% | 195.5 | 1,955 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Purchase of securities on an exchange or from another person at price $ 182.74 per share. | 30 Apr 2021 | 820 | 60,649 (0%) | 0% | 182.7 | 149,847 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Purchase of securities on an exchange or from another person at price $ 182.99 per share. | 30 Apr 2021 | 546 | 61,195 (0%) | 0% | 183.0 | 99,913 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 189.60 per share. | 19 Apr 2021 | 10 | 59,829 (0%) | 0% | 189.6 | 1,896 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 189.20 per share. | 15 Mar 2021 | 10 | 59,819 (0%) | 0% | 189.2 | 1,892 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 205.80 per share. | 16 Feb 2021 | 10 | 59,750 (0%) | 0% | 205.8 | 2,058 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 198.50 per share. | 19 Jan 2021 | 10 | 59,732 (0%) | 0% | 198.5 | 1,985 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 168.75 per share. | 21 Dec 2020 | 12 | 59,722 (0%) | 0% | 168.8 | 2,025 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 140.59 per share. | 16 Nov 2020 | 1,259 | 59,651 (0%) | 0% | 140.6 | 177,003 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 142.79 per share. | 19 Oct 2020 | 14 | 58,392 (0%) | 0% | 142.8 | 1,999 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 151.15 per share. | 21 Sep 2020 | 13 | 58,378 (0%) | 0% | 151.2 | 1,965 | Common Stock |
| Eli Lilly | Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 151.54 per share. | 17 Aug 2020 | 13 | 58,301 (0%) | 0% | 151.5 | 1,970 | Common Stock |